Discontinuation report AMERGE

Last updated on 2022-08-09 History
Report ID 148427
Drug Identification Number 02237820
Brand name AMERGE
Common or Proper name Naratriptan Tablets
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) NARATRIPTAN
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size All pack sizes/ Tous les formats
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-08-05
Remaining supply date 2024-02-17
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-10-28 English Compare
v2 2021-10-28 French Compare
v3 2022-04-06 English Compare
v4 2022-04-06 French Compare
v5 2022-07-29 English Compare
v6 2022-07-29 French Compare
v7 2022-08-05 English Compare
v8 2022-08-05 French Compare
v9 2022-08-09 English Compare
v10 2022-08-09 French Compare

Showing 1 to 10 of 10